相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening
Maria Concetta Gidaro et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Molecular docking-based screening of newly designed coumarin derivatives with potential antifungal activity against lanosterol 14 α-demethylase
Tayde Villasenor-Granados et al.
THEORETICAL CHEMISTRY ACCOUNTS (2016)
Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14α-demethylase
Alia A. Sagatova et al.
SCIENTIFIC REPORTS (2016)
Protonation Energies of 1-5-Ring Polycyclic Aromatic Nitrogen Heterocyclics: Comparing Experiment and Theory
Alexander Wiseman et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2015)
Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis
Paul A. Mann et al.
ACS INFECTIOUS DISEASES (2015)
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
A. G. S. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Proton affinity and molecular basicity of m- and p-substituted benzamides in gas phase and in solution: A theoretical study
Zaki S. Safi et al.
CHEMICAL PHYSICS LETTERS (2014)
Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity
K. N. Venugopala et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The impact of carbon-hydrogen bond dissociation energies on the prediction of the cytochrome P450 mediated major metabolic site of drug-like compounds
Kurt L. M. Drew et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study
Feng Zhu et al.
MOLECULAR INFORMATICS (2012)
Antifungal Activities of New Coumarins
Ahmed A. Al-Amiery et al.
MOLECULES (2012)
Bond stability of the undesirable heteroatom-heteroatom molecular moieties for high-throughput screening libraries
Bo Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts
N. P. Rybalchenko et al.
FITOTERAPIA (2010)
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Targeting virulence: A new paradigm for antifungals
Katharina Gauwerky et al.
DRUG DISCOVERY TODAY (2009)
Methylalpinumisoflavone Inhibits Hypoxia-inducible Factor-1 (HIF-1) Activation by Simultaneously Targeting Multiple Pathways
Yang Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
In vitro photodynarnic inactivation of Candida spp. growth and adhesion to buccal epithelial cells
Betania Maria Soares et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2009)
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
Leukothea Ioakimidis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by x-ray crystallography
Larissa M. Podust et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pavietin, a coumarin from Aesculus pavia with antifungal activity
Paolo Curir et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Invariom structure refinement, electrostatic potential and toxicity of 4-O-methylalpinumisoflavone, O,O-dimethylalpinumisoflavone and 5-O-methyl-4-O-(3-methylbut-2-en-1-yl)alpinum-isoflavone
Robert Kingsford-Adaboh et al.
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2006)
Antifungal activity of flocculosin, a novel glycolipid isolated from Pseudozyma flocculosa
B Mimee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Molecular design of two sterol 14α-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole
B Rupp et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Prediction of binding modes for ligands in the cytochromes p450 and other heme-containing proteins
SB Kirton et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice
WT Huang et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Announcing the worldwide Protein Data Bank
H Berman et al.
NATURE STRUCTURAL BIOLOGY (2003)
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa
CW Roberts et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Resistance mechanisms in clinical isolates of Candida albicans
TC White et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Invasive fungal infections: evolving challenges for diagnosis and therapeutics
M Ellis
MOLECULAR IMMUNOLOGY (2002)
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer
GP Bodey et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
MM McNeil et al.
CLINICAL INFECTIOUS DISEASES (2001)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
Evolution of drug resistance in experimental populations of Candida albicans
LE Cowen et al.
JOURNAL OF BACTERIOLOGY (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
